PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2169407
PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2169407
The global medical device contract manufacturing market is projected to reach USD 135.47 billion in 2031 from USD 85.59 billion in 2026, at a 9.6% CAGR between 2026 and 2031. Rising technological advancements in medical devices, along with an increasing geriatric population, are expected to drive the market.
| Scope of the Report | |
|---|---|
| Years Considered for the Study | 2026-2031 |
| Base Year | 2025 |
| Forecast Period | 2026-2031 |
| Units Considered | Value (USD billion) |
| Segments | By Device Type, Device Class, Service, Region |
| Regions covered | North America, Europe, Asia Pacific, Middle East & Africa, and Latin America |
The market is anticipated to grow due to continuous developments in medical fields such as robotics and minimally invasive surgery, artificial intelligence (AI) in medical devices, telemedicine, and remote patient monitoring. An aging population and rising demand for medical diagnostics further contribute to market growth. However, strict regulatory compliance and supply chain complexities are expected to limit market growth to some extent.

"By device type, the diabetes care devices segment is expected to witness the highest CAGR in the medical device contract manufacturing market."
The diabetes care devices segment is projected to experience the highest CAGR in the medical device contract manufacturing market from 2026 to 2031. This growth is driven by increasing demand for advanced diabetes management devices, including continuous glucose monitoring systems, insulin delivery devices, insulin pens, and other connected solutions. The growing complexity of these devices is encouraging diabetes care companies to outsource manufacturing activities to specialized contract manufacturers with expertise in precision components, electronics integration, automated assembly, and high-volume production. The increasing adoption of connected and wearable diabetes devices is further creating opportunities for contract manufacturers to support product development, NPI, assembly, testing, and commercial-scale manufacturing.
"The device development & manufacturing services segment accounted for the largest share of the market in 2025, by service."
The device development & manufacturing services segment commands the largest market share in the medical device contract manufacturing sector, largely because it transforms concepts into viable medical devices. Smaller enterprises and mid-sized firms often outsource these services to reduce costs, speed product timelines, and leverage specialized knowledge and advanced manufacturing techniques. This segment covers the entire product development lifecycle, from initial design and prototyping to large-scale commercialization, making it crucial for both emerging and established companies. Furthermore, escalating demand for sophisticated, high-precision medical instruments-such as minimally invasive surgical devices and wearable health monitoring technologies-has significantly increased the need for comprehensive manufacturing partnerships, further solidifying this segment's market prominence.
"Asia Pacific accounted for the largest market share in 2025."
The Asia Pacific (APAC) region is experiencing a significant surge in demand for medical device contract manufacturing services, driven by several key factors. First, rapid population growth in many countries in the region is increasing the need for advanced medical solutions. Additionally, growing awareness among healthcare providers and patients of the benefits and capabilities of modern medical devices further fuels this demand. The expanding middle class in various Asia Pacific nations is also contributing to this trend, as more consumers gain access to healthcare services and products. As a result, global leaders in the medical device contract manufacturing sector are actively establishing and expanding operations in the Asia Pacific market. These companies are introducing a variety of cutting-edge medical devices, innovative software solutions, and a diverse range of biocompatible materials tailored to different healthcare settings. In particular, China is set to dominate the APAC medical device contract manufacturing market, and it is projected to capture the largest share in 2024. This growth can be attributed to the increasing prevalence of chronic diseases, along with greater public and institutional awareness of the availability and efficacy of medical devices. As a result, the Asia Pacific region has accounted for the largest share of the market, driven by these interconnected trends and the continued evolution of the healthcare landscape.
By Company Type: Tier 1 (60%), Tier 2 (30%), and Tier 3 (10%)
By Designation: C-level Executives (30%), Directors (50%), and Other Designations (20%)
By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and the Middle East & Africa (5%)
By End User: Medical Device Manufacturers (50%), Pharmaceutical & Drug Delivery Companies (33%), and Diagnostic Companies (17%)
By Designation: Procurement/Purchasing Managers (47%), R&D/Product Development Heads (22%), Manufacturing/Engineering Heads (15%), and Others (16%)
By Region: North America (25%), Europe (24%), Asia Pacific (25%), Latin America (11%), and Middle East & Africa (15%)
Research Coverage
The report examines the medical device contract manufacturing market and estimates market size and future growth potential across segments, including device type, device class, service, and region. It also includes a competitive analysis of major players, highlighting company profiles, product and service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report helps established companies and newer or smaller firms understand market trends, enabling them to capture a larger market share. Firms that acquire the report can implement one or more of the five strategies outlined below.